Adalimumab for Crohn's disease: long-term sustained benefit in a population-based cohort of 438 patients.
Peters CP, Eshuis EJ, Toxopeüs FM, Hellemons ME, Jansen JM, D'Haens GR, Fockens P, Stokkers PC, Tuynman HA, van Bodegraven AA, Ponsioen CY; North Holland GUT club.
Peters CP, et al. Among authors: ponsioen cy.
J Crohns Colitis. 2014 Aug;8(8):866-75. doi: 10.1016/j.crohns.2014.01.012. Epub 2014 Jan 31.
J Crohns Colitis. 2014.
PMID: 24491515